Nabriva Therapeutics plans to raise $25.4M through stock sale

A Montgomery County biopharmaceutical company developing antibiotics to treat serious infections expects to raise $25.4 million in a direct stock offering this week. Nabriva Therapeutics, which has its U.S. headquarters in King of Prussia and is domiciled in Dublin, intends to use the proceeds for general corporate purposes including research and development costs, manufacturing and commercialization expenses, working capital and capital expenditures. Last summer, the company received European…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news